The pipecolinate derivative biricodar (VX-710) is a clinically applicable modulator of P-glycoprotein (Pgp) and multidrug resistance protein (MRP-1).
Administered intravenously, biricodar dicitrate is to be used in combination with cancer chemotherapy agents.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.